Filing Overview
The supplied filing is Ambac Financial Group, Inc.’s unaudited Form 10-Q for the quarter and nine months ended September 30, 2018, not Octave Specialty Group Inc. The company is a financial services holding company whose principal insurance subsidiaries are in runoff and are unable to write new business.
Business Context and Reporting Period
- Ambac’s strategy centers on runoff of Ambac Assurance and Ambac UK, loss mitigation, litigation recoveries, liability restructuring, investment management and selective evaluation of new business opportunities.
- Ambac completed its exit from rehabilitation of the Segregated Account on February 12, 2018. The transaction discharged approximately $3.86 billion of deferred policy amounts and canceled certain surplus notes.
- The company had 45.3 million common shares outstanding as of September 30, 2018. The financial statements are unaudited and interim results may not indicate full-year performance.
Financial Performance and Position
| Metric | Three months ended September 30 | Nine months ended September 30 |
|---|
| Revenue | $134.0 million in 2018 vs. $133.2 million in 2017 | $458.7 million vs. $432.7 million |
| Net income (loss) | $(22.2) million vs. $(190.9) million | $287.9 million vs. $(309.2) million |
| Net income (loss) attributable to common stockholders | $(103.8) million vs. $(190.9) million | $206.2 million vs. $(309.2) million |
| Basic EPS attributable to common stockholders | $(2.27) vs. $(4.20) | $4.52 vs. $(6.82) |
| Operating cash flow | Not separately presented for the quarter | $(1,417.9) million vs. $(245.4) million |
- Third-quarter revenue was broadly stable, but the company remained loss-making. The approximate third-quarter net loss margin was 16.5% of revenue; the nine-month margin is not meaningful because results included a large rehabilitation-related loss benefit.
- Third-quarter expenses were $154.0 million, including $65.7 million of interest expense, $33.5 million of losses and loss expenses, $26.4 million of insurance intangible amortization and $28.4 million of operating expenses.
- Nine-month losses and loss expenses were a benefit of $181.3 million, primarily reflecting the approximately $288.2 million discount benefit from the Rehabilitation Exit Transactions, partially offset by current loss development.
- Net realized investment gains were $82.2 million for the nine months, compared with $5.4 million in the prior-year period. Net investment income declined to $235.2 million from $253.9 million.
Balance Sheet, Debt and Liquidity
| Metric | September 30, 2018 | December 31, 2017 |
|---|
| Total assets | $15.09 billion | $23.19 billion |
| Total liabilities | $13.29 billion | $21.55 billion |
| Total stockholders’ equity | $1.80 billion | $1.65 billion |
| Cash and cash equivalents | $52.5 million | $623.7 million |
| Total investments | $4.28 billion | $5.74 billion |
| Ambac Assurance long-term debt | $2.94 billion | $991.7 million |
- Total assets and liabilities declined primarily because two consolidated VIEs were deconsolidated, reducing assets by approximately $6.47 billion and liabilities by approximately $6.45 billion.
- Cash, cash equivalents and restricted cash fell to $53.5 million from $624.7 million at the beginning of the year. Investing activities provided $1.25 billion, but operating and financing activities used $1.42 billion and $402 million, respectively.
- Ambac’s corporate-level cash, investments and receivables totaled approximately $463 million. Dividends from Ambac Assurance are highly unlikely in the foreseeable future, making corporate liquidity dependent on existing assets, expense reimbursements and potential tax-sharing payments.
- Debt increased materially following issuance of the approximately $2.0 billion Ambac Note and $246 million of Tier 2 Notes, partly offset by surplus-note reductions and repayment of the $74 million secured borrowing.
- Interest and principal payments on surplus notes require approval from Wisconsin’s Office of the Commissioner of Insurance. Accrued and unpaid interest on surplus notes and junior surplus notes totaled approximately $364 million at September 30, 2018.
Material Changes Versus the Prior Comparable Period
- Net income attributable to common stockholders improved to $206.2 million for the first nine months from a $309.2 million loss, largely due to the rehabilitation-exit benefit and higher realized investment gains.
- Premiums earned declined 43% in the quarter and 43% year to date, to $25.6 million and $82.4 million, respectively, reflecting continued runoff and lower acceleration activity.
- Interest expense increased to $65.7 million in the quarter and $176.2 million year to date, versus $29.1 million and $89.0 million, following the new debt issued in connection with the rehabilitation exit.
- Net loss and loss expense reserves decreased to $1.87 billion from $4.75 billion, while subrogation recoverable increased to $1.90 billion from $631.2 million. These changes principally reflect settlement of deferred amounts in the rehabilitation exit.
- The August 2018 AMPS Exchange repurchased 84.4% of outstanding auction market preferred shares, issued approximately $212.7 million of surplus notes, paid $11.0 million in cash and issued 824,307 warrants. The transaction reduced common-stockholder net income by approximately $81.7 million.
- Net insured par exposure declined to $52.2 billion from $62.7 billion, and adversely classified exposure declined to $11.1 billion from $14.1 billion.
Guidance, Outlook, Risks and Unusual Items
- No quantitative earnings guidance is provided. Management expects continued runoff, liability management, litigation and recovery efforts, and disciplined evaluation of adjacent business opportunities.
- Puerto Rico remains a principal risk. Ambac reported approximately $1.9 billion of Puerto Rico net par exposure and stated that restructuring, litigation, fiscal-plan assumptions and federal-aid uncertainty could produce losses materially exceeding current reserves.
- Management estimated that adverse stress scenarios could increase public-finance loss reserves by approximately $1.19 billion, reducing reported equity from $1.80 billion to approximately $608.8 million. The filing states that losses could exceed this amount.
- Recorded representation-and-warranty subrogation recoveries were approximately $1.75 billion net of reinsurance. If these recoveries were not realized, the filing indicates stockholders’ equity could decline to approximately $49 million.
- Ambac UK reported a Solvency II eligible-capital shortfall of approximately £282 million as of June 30, 2018; discussions with regulators were ongoing.
- Material contingencies include Puerto Rico Title III proceedings, RMBS recovery litigation, military-housing disputes, student-loan trust litigation, derivative termination rights and potential adverse legal or regulatory outcomes.
- Interest-rate, credit-spread and foreign-currency movements can materially affect fair values, reserves, collateral requirements and earnings. All identified ratings-based derivative collateral triggers had been activated.
- The company expects no material effect from recently issued accounting standards discussed in the filing, except that the future credit-loss standard is still being evaluated.
Facts Investors Should Verify
- Confirm that the filing belongs to Ambac Financial Group, Inc., rather than the company identified in the request metadata.
- Reconcile the $206.2 million year-to-date common-stockholder profit to the $81.7 million AMPS exchange charge and the $288.2 million rehabilitation-exit loss benefit.
- Assess the collectability, timing and legal priority of the approximately $1.75 billion of recorded representation-and-warranty recoveries.
- Review Puerto Rico exposure, the COFINA restructuring terms and the sensitivity of reserves to adverse public-finance outcomes.
- Evaluate liquidity relative to debt service, claims payments, collateral requirements and the restricted ability of Ambac Assurance to pay dividends or surplus-note interest.
- Review Ambac UK’s regulatory capital shortfall and the potential effects of Brexit on its European policies.
- Distinguish consolidated VIE assets and liabilities from Ambac’s direct economic obligations when analyzing leverage and liquidity.
